Recent Developments in Nanomaterials-Based Drug Delivery and Upgrading Treatment of Cardiovascular Diseases

por Mohamed, Nura A., Marei, Isra, Crovella, Sergio, Abou-Saleh, Haissam
Publicado 2022

Nanomedicine as a Potential Tool against Monkeypox

por Mohamed, Nura Adam, Zupin, Luisa, Mazi, Sarah Ismail, Al-Khatib, Hebah A., Crovella, Sergio
Publicado 2023

Think like a Virus: Toward Improving Nanovaccine Development against SARS-CoV-2

por Mohamed, Nura A., Abou-Saleh, Haissam, Mohamed, Hana A., Al-Ghouti, Mohammad A., Crovella, Sergio, Zupin, Luisa
Publicado 2022

Role of prostacyclin in pulmonary hypertension

por Mitchell, Jane A., Ahmetaj-Shala, Blerina, Kirkby, Nicholas S., Wright, William R., Mackenzie, Louise S., Reed, Daniel M., Mohamed, Nura
Publicado 2014

Evaluation of Metal‐Organic Framework MIL-89 nanoparticles toxicity on embryonic zebrafish development

por Al-Ansari, Dana E., Al-Badr, Mashael, Zakaria, Zain Z., Mohamed, Nura Adam, Nasrallah, Gheyath K., Yalcin, Huseyin C., Abou-Saleh, Haissam
Publicado 2022

Internalization of Metal–Organic Framework Nanoparticles in Human Vascular Cells: Implications for Cardiovascular Disease Therapy

por Al-Ansari, Dana E., Mohamed, Nura A., Marei, Isra, Zekri, Atef, Kameno, Yu, Davies, Robert P., Lickiss, Paul D., Rahman, Md Mizanur, Abou-Saleh, Haissam
Publicado 2020

P2Y(12) receptor blockade synergizes strongly with nitric oxide and prostacyclin to inhibit platelet activation

por Chan, Melissa V., Knowles, Rebecca B. M., Lundberg, Martina H., Tucker, Arthur T., Mohamed, Nura A., Kirkby, Nicholas S., Armstrong, Paul C. J., Mitchell, Jane A., Warner, Timothy D.
Publicado 2016

Activation and Contraction of Human “Vascular” Smooth Muscle Cells Grown From Circulating Blood Progenitors

por Ahmetaj-Shala, Blerina, Marei, Isra, Kawai, Ryota, Rothery, Stephen, Pericleous, Charis, Mohamed, Nura A., Gashaw, Hime, Bokea, Kalliopi, Samuel, Jake, Vandenheste, Annabelle, Shala, Fisnik, Kirkby, Nicholas S., Mitchell, Jane A.
Publicado 2021

Studies on metal–organic framework (MOF) nanomedicine preparations of sildenafil for the future treatment of pulmonary arterial hypertension

por Mohamed, Nura A., Abou-Saleh, Haissam, Kameno, Yu, Marei, Isra, de Nucci, Gilberto, Ahmetaj-Shala, Blerina, Shala, Fisnik, Kirkby, Nicholas S., Jennings, Lewis, Al-Ansari, Dana E., Davies, Robert P., Lickiss, Paul D., Mitchell, Jane A.
Publicado 2021

In Vitro and In Vivo Validation of GATA-3 Suppression for Induction of Adipogenesis and Improving Insulin Sensitivity

por Al-Jaber, Hend, Mohamed, Nura A., Govindharajan, Vijay K., Taha, Samir, John, Jomon, Halim, Sharique, Alser, Maha, Al-Muraikhy, Shamma, Anwardeen, Najeha Rizwana, Agouni, Abdelali, Elhissi, Abdelbary, Al-Naemi, Hamda A., Al-Mansoori, Layla, Elrayess, Mohamed A.
Publicado 2022

A New NO-Releasing Nanoformulation for the Treatment of Pulmonary Arterial Hypertension

por Mohamed, Nura A., Ahmetaj-Shala, Blerina, Duluc, Lucie, Mackenzie, Louise S., Kirkby, Nicholas S., Reed, Daniel M., Lickiss, Paul D., Davies, Robert P., Freeman, Gemma R., Wojciak-Stothard, Beata, Chester, Adrian H., El-Sherbiny, Ibrahim M., Mitchell, Jane A., Yacoub, Magdi H.
Publicado 2016

Chemical and biological assessment of metal organic frameworks (MOFs) in pulmonary cells and in an acute in vivo model: relevance to pulmonary arterial hypertension therapy

por Mohamed, Nura A., Davies, Robert P., Lickiss, Paul D., Ahmetaj-Shala, Blerina, Reed, Daniel M., Gashaw, Hime H., Saleem, Hira, Freeman, Gemma R., George, Peter M., Wort, Stephen J., Morales-Cano, Daniel, Barreira, Bianca, Tetley, Teresa D., Chester, Adrian H., Yacoub, Magdi H., Kirkby, Nicholas S., Moreno, Laura, Mitchell, Jane A.
Publicado 2017